Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
Clinical trial NCT01501669 · UNKNOWN
Trial details
- NCT number
- NCT01501669
- Sponsor
- National Cancer Center, Korea
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.